These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The T cell receptor abnormalities and autoimmune diseases]. Takeno M; Sakane T Tanpakushitsu Kakusan Koso; 1990 Apr; 35(5):865-73. PubMed ID: 2362962 [No Abstract] [Full Text] [Related]
6. Off-the-shelf CAR T cells for refractory autoimmunity. Papatriantafyllou M Nat Rev Rheumatol; 2024 Sep; 20(9):527. PubMed ID: 39075289 [No Abstract] [Full Text] [Related]
7. Autoimmunity: physiologic and pernicious. Cohen IR Adv Intern Med; 1984; 29():147-65. PubMed ID: 6201052 [No Abstract] [Full Text] [Related]
8. Major histocompatibility complex-linked control of autoimmunity. Wicker LS J Exp Med; 1997 Oct; 186(7):973-5. PubMed ID: 9379141 [No Abstract] [Full Text] [Related]
9. Autoimmunity. Thoughts for the millennium. Mackay IR; Van de Water J; Gershwin ME Clin Rev Allergy Immunol; 2000 Feb; 18(1):87-117. PubMed ID: 10907110 [No Abstract] [Full Text] [Related]
10. Understanding multiple sclerosis: new immunologic insights and prospects for specific therapy. Ransohoff RM Compr Ther; 1991 Nov; 17(11):3-6. PubMed ID: 1799959 [No Abstract] [Full Text] [Related]
12. Insights into autoimmunity: from classical models to current perspectives. Gutierrez-Ramos JC; Andreu JL; Moreno de Alboran I; Rodriguez J; Leonardo E; Kroemer G; Marcos MA; Martinez C Immunol Rev; 1990 Dec; 118():73-101. PubMed ID: 2079329 [No Abstract] [Full Text] [Related]
13. [The current outlook in the therapy of autoimmune diseases]. Sebastiani GD; Passiu G Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130 [TBL] [Abstract][Full Text] [Related]
14. B cell immunobiology in disease: evolving concepts from the clinic. Martin F; Chan AC Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256 [TBL] [Abstract][Full Text] [Related]
16. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease]. Miller A; Weiner HL; Abramsky O Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860 [No Abstract] [Full Text] [Related]
17. The use of monoclonal antibodies to achieve immunological tolerance. Waldmann H; Cobbold S Trends Pharmacol Sci; 1993 May; 14(5):143-8. PubMed ID: 8212308 [TBL] [Abstract][Full Text] [Related]
18. T-cell receptor transgenic mice in the study of autoimmune diseases. Lafaille JJ J Autoimmun; 2004 Mar; 22(2):95-106. PubMed ID: 14987736 [TBL] [Abstract][Full Text] [Related]
19. The use of monoclonal antibodies to achieve immunological tolerance. Waldmann H; Cobbold S Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765 [TBL] [Abstract][Full Text] [Related]
20. OX40/OX40L axis: not a friend in autoimmunity. Ueno H; Blanco P Oncotarget; 2015 Sep; 6(26):21779-80. PubMed ID: 26314852 [No Abstract] [Full Text] [Related] [Next] [New Search]